Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM

Código QR

Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM

Xu Wu, Yashan Li, Baohua Man, Dexuan Li The Third People’s Hospital of Yunnan Province, Department of Clinical Laboratory, Kunming, 650200, People’s Republic of ChinaCorrespondence: Dexuan LiDepartment of Clinical Laboratory, The Third People’s Hospital of Yunnan Provin...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wu X, Li Y, Man B, Li D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	c-peptide insulin microrna-375 ogtt type 2 diabetes mellitus Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/c7e1ed7761ae4cfc9b7ecf6b62dd20bf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Dietary Knowledge, Attitude and Practice (KAP) Among the Family Members of Patients with Type 2 Diabetes Mellitus (T2DM) and Its Influence on the KAP of T2DM Patients
por: Hu X, et al.
Publicado: (2021)

Efficacy and Safety of a Decision Support Intervention for Basal Insulin Self-Titration Assisted by the Nurse in Outpatients with T2DM: A Randomized Controlled Trial
por: Hu X, et al.
Publicado: (2021)

Canagliflozin review – safety and efficacy profile in patients with T2DM
por: Jakher H, et al.
Publicado: (2019)

MicroRNAs: Marcadores séricos en diabetes mellitus tipo 2 y ejercicio físico
por: Gómez-Banoy,Nicolás, et al.
Publicado: (2016)

Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
por: Mussa BM, et al.
Publicado: (2021)

Association Analysis of Insulin Resistance and Osteoporosis Risk in Chinese Patients with T2DM
por: Wang X, et al.
Publicado: (2021)

Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient
por: Xu D, et al.
Publicado: (2021)

Aspects to Consider for a More Useful, Discriminative Predictive Tool for CAP Mortality in T2DM [Letter]
por: Geltser D
Publicado: (2021)

Comparison of Diabetes-Dependent Quality of Life (ADDQoL) in Patients with T2DM in Poland, The Czech Republic, and Slovakia
por: Krzemińska S, et al.
Publicado: (2020)

ANGPTL8 Gene Polymorphism rs2278426 Is Related to Carotid Intima–Media Thickness in T2DM
por: Guo C, et al.
Publicado: (2020)

Insulin initiation and intensification in patients with T2DM for the primary care physician
por: Unger J
Publicado: (2011)

Genetic variants linked to T2DM risk in Kurdish populations [Retraction]
por: Golsheh S, et al.
Publicado: (2019)

E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375
por: Pengfei Li, et al.
Publicado: (2021)

Genetic variants linked to T2DM risk in Kurdish populations
por: Golsheh S, et al.
Publicado: (2019)

Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
por: Wondmkun YT
Publicado: (2020)

TLR4 Polymorphisms (896A>G and 1196C>T) Affect the Predisposition to Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Khaghanzadeh N, et al.
Publicado: (2020)

Chaperone-Based Therapeutic Target Innovation: Heat Shock Protein 70 (HSP70) for Type 2 Diabetes Mellitus
por: Mulyani WRW, et al.
Publicado: (2020)

Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
por: Kalirai S, et al.
Publicado: (2020)

Relationship of microRNA locus with type 2 diabetes mellitus: a case–control study
por: Qiuyu Huang, et al.
Publicado: (2021)

Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Liu D, et al.
Publicado: (2021)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau IT, et al.
Publicado: (2017)

The Association Between Insulin Resistance, Leptin, and Resistin and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients with Different Body Mass Indexes
por: Huang J, et al.
Publicado: (2021)

The Association Between Prediabetes and Dyslipidemia Among Attendants of Primary Care Health Centers in Jeddah, Saudi Arabia
por: Al Amri T, et al.
Publicado: (2019)

Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats
por: Mi J, et al.
Publicado: (2019)

MicroRNAs and Risk Factors for Diabetic Nephropathy in Egyptian Children and Adolescents with Type 1 Diabetes
por: Abdelghaffar S, et al.
Publicado: (2020)

Resultados de un programa multidisciplinario de tratamiento intensificado de la Diabetes Mellitus tipo 1 (DM1) en un Hospital Público
por: Codner D,Ethel, et al.
Publicado: (2003)

Effects of Adiponectin on T2DM and Glucose Homeostasis: A Mendelian Randomization Study
por: Chen Z, et al.
Publicado: (2020)

Long‐term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome
por: Albai O, et al.
Publicado: (2020)

Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study
por: Ji L, et al.
Publicado: (2016)

The Oral Glucose Tolerance Test: 100 Years Later
por: Jagannathan R, et al.
Publicado: (2020)

Assessing routine healthcare pattern for type 2 diabetes mellitus in Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2)
por: Ivan I. Dedov, et al.
Publicado: (2016)

Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
por: Pollock RF, et al.
Publicado: (2018)

Khat Chewing and Type 2 Diabetes Mellitus
por: Badedi M, et al.
Publicado: (2020)

Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
por: Tafere GG, et al.
Publicado: (2020)

“Adjusting Internal Organs and Dredging Channel” Electroacupuncture Ameliorates Insulin Resistance in Type 2 Diabetes Mellitus by Regulating the Intestinal Flora and Inhibiting Inflammation
por: Zhang L, et al.
Publicado: (2021)

Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study
por: Chen P, et al.
Publicado: (2020)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Schwartz S
Publicado: (2010)

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice
por: Lee J, et al.
Publicado: (2019)

One-hour postload plasma glucose levels as a new criterion for assessing insulin secretion in obese children
por: O. V. Vasyukova, et al.
Publicado: (2021)

Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus
por: Liang ZH, et al.
Publicado: (2019)